Zynex Profit Margin 2011-2025 | ZYXI

Current and historical gross margin, operating margin and net profit margin for Zynex (ZYXI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Zynex net profit margin as of June 30, 2025 is -19.79%.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.035B $0.192B
Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $220.837B 25.45
EssilorLuxottica (ESLOY) France $169.692B 0.00
Boston Scientific (BSX) United States $151.950B 34.75
Stryker (SYK) United States $139.087B 27.62
Medtronic (MDT) Ireland $122.368B 17.25
Lonza Group Ag (LZAGY) Switzerland $48.739B 0.00
Agilent Technologies (A) United States $42.361B 27.42
ResMed (RMD) United States $36.840B 25.50
GE HealthCare Technologies (GEHC) United States $33.440B 15.99
Koninklijke Philips (PHG) Netherlands $28.242B 18.45
Terumo (TRUMY) Japan $24.252B 28.74
Insulet (PODD) United States $22.953B 71.24
Zimmer Biomet Holdings (ZBH) United States $17.539B 10.94
Smith & Nephew SNATS (SNN) United Kingdom $14.204B 0.00
Baxter (BAX) United States $9.382B 7.57
Sunny Optical Technology (SNPTF) China $9.339B 0.00
Bio-Rad Laboratories (BIO) United States $8.452B 30.39
Demant (WILYY) Denmark $7.496B 0.00
Lantheus Holdings (LNTH) United States $3.539B 10.78
ICU Medical (ICUI) United States $3.536B 22.45
Haemonetics (HAE) United States $3.358B 14.94
Envista Holdings (NVST) United States $3.323B 19.07
Shandong Weigao Medical Polymer (SHWGF) China $3.120B 0.00
Prestige Consumer Healthcare (PBH) United States $2.913B 13.28
LeMaitre Vascular (LMAT) United States $2.050B 41.26
Perrigo (PRGO) Ireland $1.968B 4.93
Curaleaf Holdings (CURLF) Canada $1.896B 0.00
Phibro Animal Health (PAHC) United States $1.837B 18.35
AtriCure (ATRC) United States $1.634B 0.00
Green Thumb Industries (GTBIF) United States $1.504B 65.91
QuidelOrtho (QDEL) United States $1.487B 9.56
Tilray Brands (TLRY) Canada $1.448B 0.00
Neogen (NEOG) United States $1.419B 27.21
Kestra Medical Technologies (KMTS) United States $1.418B 0.00
AdaptHealth (AHCO) United States $1.291B 18.71
BioLife Solutions (BLFS) United States $1.254B 372.00
InMode (INMD) Israel $0.917B 10.36
Maravai LifeSciences Holdings (MRVI) United States $0.830B 0.00
Valneva SE (VALN) France $0.764B 0.00
Surmodics (SRDX) United States $0.585B 0.00
VAREX IMAGING (VREX) United States $0.517B 17.80
SNDL (SNDL) Canada $0.486B 0.00
Verano Holdings (VRNO) United States $0.481B 0.00
Omeros (OMER) United States $0.469B 0.00
CeriBell (CBLL) United States $0.464B 0.00
Evolus (EOLS) United States $0.453B 0.00
Cresco Labs (CRLBF) United States $0.431B 0.00
Cerus (CERS) United States $0.317B 0.00
Sanuwave Health (SNWV) United States $0.303B 0.00
Brainsway (BWAY) Israel $0.288B 50.60
Canopy Growth (CGC) Canada $0.288B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.286B 0.00
Capricor Therapeutics (CAPR) United States $0.283B 0.00
High Tide (HITI) Canada $0.261B 0.00
Aurora Cannabis (ACB) Canada $0.256B 151.67
Sanara MedTech (SMTI) United States $0.250B 0.00
Viemed Healthcare (VMD) United States $0.241B 19.24
Quanterix (QTRX) United States $0.234B 0.00
TerrAscend (TSNDF) Canada $0.224B 0.00
Organigram Global (OGI) Canada $0.221B 0.00
Owens & Minor (OMI) United States $0.220B 2.21
TriSalus Life Sciences (TLSI) United States $0.216B 0.00
Exagen (XGN) United States $0.209B 0.00
Vireo Growth (VREOF) United States $0.195B 0.00
Utah Medical Products (UTMD) United States $0.183B 16.16
FitLife Brands (FTLF) United States $0.180B 22.17
OraSure Technologies (OSUR) United States $0.176B 0.00
Apyx Medical (APYX) United States $0.153B 0.00
Biote (BTMD) United States $0.129B 5.21
Jushi Holdings (JUSHF) United States $0.128B 0.00
Quipt Home Medical (QIPT) United States $0.103B 0.00
Sharps Technology (STSS) United States $0.103B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.099B 0.00
MacroGenics (MGNX) United States $0.096B 0.00
Fonar (FONR) United States $0.092B 13.33
Agape ATP (ATPC) $0.065B 0.00
ImmuCell (ICCC) United States $0.057B 33.00
Nephros (NEPH) United States $0.046B 33.31
Cytosorbents (CTSO) United States $0.044B 0.00
Jin Medical (ZJYL) China $0.039B 0.00
Veru (VERU) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.036B 0.00
Bonk (BNKK) United States $0.033B 0.00
United-Guardian (UG) United States $0.029B 14.77
Modular Medical (MODD) United States $0.027B 0.00
Allurion Technologies (ALUR) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
INLIF (INLF) China $0.010B 0.00
IM Cannabis (IMCC) Canada $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.007B 0.00
Flora Growth (FLGC) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Innovative Eyewear (LUCY) United States $0.005B 0.00
Akanda (AKAN) Canada $0.001B 0.00
InterCure (INCR) Israel $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00